Repligen (RGEN) Q2 Earnings: What To Expect
Repligen (RGEN) is set to report its Q2 earnings this Tuesday morning. Analysts expect the biopharma manufacturing company's revenue to grow 10.7% year over year, a slowdown from the previous year. The company beat revenue and EPS expectations last quarter, and analysts have generally …